Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 750
Single User License Price INR 51465
Corporate User License Price USD 2250
Corporate User License Price INR 154395
Site License Price USD 1500
Site License Price INR 102930
Request a Quote

Report Title

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

Quote Request for License Type
License Type Price  
Single User License USD 750
Site License USD 1500
Enterprise Wide License USD 2250
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update


Quote Request for License Type
License Type Price  
Single User License USD 750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update



Executive Summary

Summary

Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes translocation testing, aneuploidy screening, and single gene testing. Natera offers constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests. The company also undertakes clinical trial of several genetic materials. Natera is headquartered in San Carlos, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Natera Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Natera Inc Company Overview 6

Natera Inc Company Snapshot 6

Natera Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Natera Inc-Pipeline Analysis Overview 9

Natera Inc-Key Facts 9

Natera Inc-Major Products and Services 10

Natera Inc Pipeline Products by Development Stage 11

Natera Inc Ongoing Clinical Trials by Trial Status 14

Natera Inc Pipeline Products Overview 16

Anora Natera Miscarriage POC Test 16

Anora Natera Miscarriage POC Test Product Overview 16

Constellation 17

Constellation Product Overview 17

dd-cfDNA Assay-Kidney Transplant Rejection 18

dd-cfDNA Assay-Kidney Transplant Rejection Product Overview 18

Horizon Carrier Screen Test 19

Horizon Carrier Screen Test Product Overview 19

Non-Invasive DNA Based Test- Breast Cancer 20

Non-Invasive DNA Based Test- Breast Cancer Product Overview 20

Non-Invasive DNA Based Test- Lung Cancer 21

Non-Invasive DNA Based Test- Lung Cancer Product Overview 21

Non-Invasive DNA Based Test- Ovarian Cancer 22

Non-Invasive DNA Based Test- Ovarian Cancer Product Overview 22

Non-invasive DNA Based Test-Therapeutic Monitoring 23

Non-invasive DNA Based Test-Therapeutic Monitoring Product Overview 23

Panorama Non-Invasive Prenatal Expanded Test 24

Panorama Non-Invasive Prenatal Expanded Test Product Overview 24

Panorama Non-Invasive Prenatal Expanded Test Clinical Trial 25

Signatera-Breast Cancer 27

Signatera-Breast Cancer Product Overview 27

Signatera-Colorectal Cancer 28

Signatera-Colorectal Cancer Product Overview 28

Spectrum PGD Test 29

Spectrum PGD Test Product Overview 29

Spectrum PGS Test 30

Spectrum PGS Test Product Overview 30

Vistara Non-Invasive Prenatal Test 31

Vistara Non-Invasive Prenatal Test Product Overview 31

Vistara Non-Invasive Prenatal Test Clinical Trial 32

Natera Inc-Key Competitors 33

Natera Inc-Key Employees 34

Natera Inc-Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Recent Developments 36

Natera Inc, Recent Developments 36

Jun 21, 2018: Natera Develops Powerful Kidney Transplant Rejection Biomarker 36

Jun 19, 2018: Natera and Institut Jules Bordet partner on breast cancer research 36

Jun 13, 2018: Natera Announces New Clinical Utility Data and Issuance of CPT Code for NIPT in Twin Pregnancies 37

May 09, 2018: ECRI Institute Reveals Important Differences in Prenatal Genetic Tests 37

May 08, 2018: Natera Reports First Quarter 2018 Financial Results 38

Apr 13, 2018: Natera to Present Successful Results at AACR from Bladder and Colon Cancer Studies 39

Apr 09, 2018: Natera Appoints Paul R. Billings, M.D., Ph.D., as Chief Medical Officer 39

Mar 13, 2018: Natera Announces Fourth Quarter And Fiscal Year 2017 Financial Results 40

Mar 05, 2018: Natera's Genetic Tests Now Fully Integrated into Yale New Haven Health's Epic EMR System 41

Jan 29, 2018: Natera To Feature Expanded Panorama Non-Invasive Prenatal Test, Now Validated for Twin Pregnancies, at SMFM Annual Meeting 42

Appendix 43

Methodology 43

About GlobalData 46

Contact Us 46

Disclaimer 46

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Natera Inc Pipeline Products by Equipment Type 7

Natera Inc Pipeline Products by Development Stage 11

Natera Inc Ongoing Clinical Trials by Trial Status 14

List of Tables

Natera Inc Pipeline Products and Ongoing Clinical Trials Overview 6

Natera Inc Pipeline Products by Equipment Type 7

Natera Inc Pipeline Products by Indication 8

Natera Inc Ongoing Clinical Trials by Trial Status 8

Natera Inc, Key Facts 9

Natera Inc, Major Products and Services 10

Natera Inc Number of Pipeline Products by Development Stage 11

Natera Inc Pipeline Products Summary by Development Stage 12

Natera Inc Ongoing Clinical Trials by Trial Status 14

Natera Inc Ongoing Clinical Trials Summary 15

Anora Natera Miscarriage POC Test-Product Status 16

Anora Natera Miscarriage POC Test-Product Description 16

Constellation-Product Status 17

Constellation-Product Description 17

dd-cfDNA Assay-Kidney Transplant Rejection-Product Status 18

dd-cfDNA Assay-Kidney Transplant Rejection-Product Description 18

Horizon Carrier Screen Test-Product Status 19

Horizon Carrier Screen Test-Product Description 19

Non-Invasive DNA Based Test- Breast Cancer-Product Status 20

Non-Invasive DNA Based Test- Breast Cancer-Product Description 20

Non-Invasive DNA Based Test- Lung Cancer-Product Status 21

Non-Invasive DNA Based Test- Lung Cancer-Product Description 21

Non-Invasive DNA Based Test- Ovarian Cancer-Product Status 22

Non-Invasive DNA Based Test- Ovarian Cancer-Product Description 22

Non-invasive DNA Based Test-Therapeutic Monitoring-Product Status 23

Non-invasive DNA Based Test-Therapeutic Monitoring-Product Description 23

Panorama Non-Invasive Prenatal Expanded Test-Product Status 24

Panorama Non-Invasive Prenatal Expanded Test-Product Description 24

Panorama Non-Invasive Prenatal Expanded Test-Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated from Maternal Blood 25

Panorama Non-Invasive Prenatal Expanded Test-Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated from Maternal Blood 25

Panorama Non-Invasive Prenatal Expanded Test-Development of Non-invasive Prenatal Test for Microdeletion/Duplication and Other Genetic Syndromes Based on Fetal DNA Isolated from Maternal Blood 25

Panorama Non-Invasive Prenatal Expanded Test-SNP-based Microdeletion and Aneuploidy Registry 26

Signatera-Breast Cancer-Product Status 27

Signatera-Breast Cancer-Product Description 27

Signatera-Colorectal Cancer-Product Status 28

Signatera-Colorectal Cancer-Product Description 28

Spectrum PGD Test-Product Status 29

Spectrum PGD Test-Product Description 29

Spectrum PGS Test-Product Status 30

Spectrum PGS Test-Product Description 30

Vistara Non-Invasive Prenatal Test-Product Status 31

Vistara Non-Invasive Prenatal Test-Product Description 31

Vistara Non-Invasive Prenatal Test-Development of Non-invasive Prenatal Diagnostic Test for Multiple Gestation Pregnancies Based on Fetal DNA Isolated from Maternal Blood 32

Natera Inc, Key Employees 34

Natera Inc, Subsidiaries 35

Glossary 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Sequenom Inc

Novartis AG

Myriad Genetics Inc

Illumina Inc

Genomic Health Inc

Natera Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person